ACS omega · 2024
Choline Chloride-Urea Deep Eutectic Solvent/Cu-Mn Iminodiacetate Coordination Polymer as an Efficient Catalytic System for Synthesis of Morita-Baylis-Hillman Adducts with Antimicrobial Activity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mendes Rhuan Karlos Santos, Santos Emelly Suelen de Freitas Reis, de Andrade Sandro Dutra, da Silva Girlyanderson Araújo, Galvão José Lucas Ferreira Marques, Dos Santos José Roberto Dantas de Andrade, Lima Edeltrudes de Oliveira, da Silva Rodolfo B, Cristiano Rodrigo, da Silva Fausthon Fred, Lima-Junior Claudio Gabriel
Аннотация
This work shows the synthesis of a series of Morita-Baylis-Hillman adducts from isatin derivatives via an efficient green approach involving the use of a new catalyst system, a mixture of copper-manganese iminodiacetate 1D coordination polymer (Cu/Mn-IDA) and choline chloride-urea deep eutectic solvent (ChCl/urea 1:2). The adducts 2a-2i were obtained in good to excellent yields (59-97%) with shorter reaction times. The results demonstrate for the first time the synergistic catalytic effect of the combination of deep eutectic solvent and coordination polymer on the Morita-Baylis-Hillman reactions. The catalyst recyclability was investigated, and it was found that Cu/Mn-IDA maintains consistent performance for at least four catalytic cycles. The synthesized compounds were evaluated for their in vitro antimicrobial activity against four bacteria and eight fungi species. Among all, 2a, 2b, 2d, 2e, and 2g showed antifungal and antibacterial activities in 70-83% of the strains tested. The adduct 2e exhibited significant antifungal activity with a minimum inhibitory concentration value of 128 μg mL-1 compared to the standard drug fluconazole (minimum inhibitory concentration, 256 μg mL-1).